Neutralizing antibodies to Escherichia coli vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents

Journal of Clinical Microbiology

Volumn 34, Issue 9, 1996, Pages 2053-2057

  Reymond, D ^a,b   Johnson, R P ^c   Karmali, M A ^a,b,e   Petric, M ^a,b   Winkler, M ^a   Johnson, S ^c   Rahn, K ^c   Renwick, S ^c   Wilson, J ^c,d   Clarke, R C ^c   Spika, J ^d  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^d HEALTH CANADA   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; VEROTOXIN;

AGRICULTURAL WORKER; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENTEROBACTER INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; URBAN POPULATION;

BACTERIA (MICROORGANISMS); ENTEROBACTER; ESCHERICHIA COLI; TRIXIS;

EID: 9444248206     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.9.2053-2057.1996     Document Type: Article

References (41)

1. Ashkenazi, S., T. G. Cleary, E. Lopez, and L. K. Pickering. 1988. Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome. J. Pediatr. 113:1008-1014.
2. Bitzan, M., and H. Karch. 1992. Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome. J. Clin. Microbiol. 30:1174-1178.
3. Bitzan, M., K. Ludwig, M. Klemt, H. König, J. Büren, and D. E. Müller-Wiefel. 1993. The role of Escherichia coli O157 infections in the classical (enteropathogenic) haemolytic uraemic syndrome: results of a central European, multicentre study. Epidemiol. Infect. 110:183-196.
4. Borman-Eby, H. C., S. A. McEwen, R. C. Clarke, W. B. McNab, K. Rahn, and A. Valdivieso-Garcia. 1993. The seroprevalence of verocytotoxigenic Escherichia coli in Ontario dairy cows and associations with production and management. Prevent. Vet. Med. 15:261-274.
5. Caprioli, A., I. Luzzi, F. Rosmini, P. Pasquini, R. Cirrincione, A. Gianviti, M. C. Matteucci, G. Rizzoni, and the HUS Italian Study Group. 1992. Hemolytic-uremic syndrome and Vero cytotoxin-producing Escherichia coli infection in Italy. J. Infect. Dis. 166:154-158.
6. Caprioli, A., I. Luzzi, L. Seganti, M. Marchetti, M. Karmali, I. Clarke, and B. Boyd. 1994. Frequency and nature of verocytotoxin 2 (VT2) neutralizing activity (NA) in human and animal sera, p. 353-356. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in Verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam.
7. Chart, H., O. A. Okubadejo, and B. Rowe. 1992. The serological relationship between Escherichia coli and Yersinia enterocolitica O9 using sera from patients with brucellosis. Epidemiol. Infect. 108:77-85.
8. Chart, H., and B. Rowe. 1992. Improved detection of infection by Escherichia coli O157 in patients with haemolytic uraemic syndrome by means of IgA antibodies to lipopolysaccharide. J. Infect. 24:257-261.
9. Chart, H., S. M. Scotland, and B. Rowe. 1989. Serum antibodies to Escherichia coli O157:H7 in patients with hemolytic-uremic syndrome. J. Clin. Microbiol. 27:285-290.
10. Chart, H., H. R. Smith, S. M. Scotland, B. Rowe, D. Milford, and C. M. Taylor. 1991. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet 337:138-140.
11. Clarke, R. C., J. B. Wilson, S. C. Read, S. Renwick, K. Rahn, R. P. Johnson, D. Alves, M. A. Karmali, H. Lior, S. A. McEwen, J. Spika, and C. L. Gyles. 1994. Verocytotoxin-producing Escherichia coli (VTEC) in the food chain: preharvest and processing perspectives, p. 17-24. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in Verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam.
12. Cohen, A., V. Madrid-Marina, Z. Estrov, M. Freedman, C. A. Lingwood, and H. Dosch. 1990. Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. Int. Immunol. 2:1-8.
13. Conedera, G., A. Zuin, and S. Marangon. 1994. Seroprevalence of neutralizing antibodies to Escherichia coli verocytotoxins in domestic and wild animals in Italy, p. 81-84. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in Verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam.
14. Dodds, K. L., M. B. Perry, and I. J. McDonald. 1987. Electrophoretic and immunochemical study of the lipopolysaccharides produced by chemostat-grown Escherichia coli O157. J. Gen. Microbiol. 133:2679-2687.
15. Greatorex, J. S., and G. M. Thorne. 1994. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects. J. Clin. Microbiol. 32:1172-1178.
16. Griffin, P. M., and R. V. Tauxe. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol. Rev. 13:60-98.
17. Karmali, M. A. 1992. The association of Verocytotoxins and the classical hemolytic uremic syndrome, p. 199-212. In B. S. Kaplan, R. S. Trompeter, and J. L. Moake (ed.), Hemolytic uremic syndrome and thrombocytopenic purpura. Marcel Dekker, Inc., New York.
18. Karmali, M. A., M. Petric, C. Lim, P. C. Fleming, G. S. Arbus, and H. Lior. 1985. The association between hemolytic uremic syndrome and infection by Verotoxin-producing Escherichia coli. J. Infect. Dis. 151:775-782.
19. Karmali, M. A., M. Petric, M. Winkler, M. Bielaszewska, J. Brunton, N. van de Kar, T. Morooka, G. Balakrishna Nair, S. E. Richardson, and G. S. Arbus. 1994. Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1. J. Clin. Microbiol. 32:1457-1463.
20. Karmali, M. A., B. T. Steele, M. Petric, and C. Lim. 1983. Sporadic cases of hemolytic uremic syndrome associated with fecal cytotoxin and cytotoxin-producing Escherichia coli. Lancet i:619-620.
21. Levine, M. M., J. McEwen, G. L. Osonsky, M. Reymann, I. Harari, J. E. Brown, D. N. Taylor, A. Donohue-Rolfe, D. Cohen, M. Bennish, Y. L. Lim, and R. Arnon. 1992. Antibodies to Shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery. J. Clin. Microbiol. 30:1636-1641.
22. Lingwood, C. A., H. Law, S. E. Richardson, M. Petric, J. L. Brunton, S. De Grandis, and M. Karmali. 1987. Glycolipid binding of natural and recombinant Escherichia coli produced verotoxin in vitro. J. Clin. Chem. 262:8834-8839.
23. Lopez, E. L., M. Diaz, S. Devoto, S. Grinstein, M. Woloj, B. E. Murray, E. Rubeglio, F. Mendilaharzu, M. Turco, M. Vasquez, L. K. Pickering, and T. G. Cleary. 1991. Evidence of infection with organisms producing Shiga-like toxins in household contacts of children with hemolytic uremic syndrome. Pediatr. Infect. Dis. J. 10:20-24.
24. Lopez, E. L., M. Diaz, S. Grinstein, S. Devoto, F. Mendilaharzu, B. E. Murray, S. Ashkenazi, E. Rubeglio, M. Woloj, M. Vasquez, M. Turco, L. K. Pickering, and T. G. Cleary. 1989. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J. Infect. Dis. 160:469-475.
25. Lopez, E. L., C. A. Gianantonio, and T. G. Cleary. 1992. HUS in Argentina, p. 89-96. In B. S. Kaplan, R. S. Trompeter, and J. L. Moake (ed.), Hemolytic uremic syndrome and thrombocytopenic purpura. Marcel Dekker, Inc., New York.
26. Luzzi, I., C. Farina, A. Goglio, U. Scardellato, P. Pizzocaro, I. Benedetti, F. Minelli, and A. Caprioli. 1994. Seroprevalence of neutralizing antibodies to Escherichia coli verotoxins in the population of two Italian regions, p. 85-88. In M. A. Karmali, and A. G. Goglio (ed.), Recent advances in Verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam.
27. Notenboom, R. H., A. Borczyk, M. A. Karmali, and L. M. C. Duncan. 1987. Clinical relevance of a serological cross-reaction between Escherichia coli O157 and Brucella abortus. Lancet ii:745.
28. O'Brien, A. D., M. A. Karmali, and S. M. Scotland. 1994. A proposal for rationalizing the nomenclature of the Escherichia coli cytotoxins, p. 147-149. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in Verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam.
29. Obrig, T. G. 1992. Pathogenesis of Shiga toxin (Verotoxin)-induced endothelial cell injury, p. 405-419. In B. S. Kaplan, R. S. Trompeter, and J. L. Moake (ed.), Hemolytic uremic syndrome and thrombocytopenic purpura. Marcel Dekker, Inc., New York.
30. Ostroff, S. M., P. J. Tarr, M. A. Neill, J. H. Lewis, N. Hargrett-Bean, and J. M. Kobayashi. 1989. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J. Infect. Dis. 160:994-998.
31. Pai, C. H., N. Ahmed, H. Lior, W. M. Johnson, H. V. Sims, and D. E. Woods. 1988. Epidemiology of sporadic diarrhea due to Verocytotoxin-producing Escherichia coli: a two-year prospective study. J. Infect. Dis. 157:1054-1057.
32. Perry, M. B., and D. R. Bundle. 1990. Antigenic relationships of the lipopolysaccharides of Escherichia hermanii strains with those of Escherichia coli O157:H7, Brucella melitensis and Brucella abortus. Infect. Immun. 58:1391-1395.
33. Perry, M. B., D. R. Bundle, L. MacLean, J. A. Perry, and D. W. Griffith. 1986. The structure of the antigenic lipopolysaccharide O chain produced by Salmonella urbana and Salmonella godesberg. Carbohydr. Res. 156:107-122.
34. Pirro, F., L. H. Wieler, K. Failing, R. Bauerfeind, and G. Baljer. 1995. Neutralizing antibodies against Shiga-like toxins from Escherichia coli in colostra and sera from cattle. Vet. Microbiol. 43:131-141.
35. Riley, L. W., R. S. Remis, S. D. Helgerson, H. B. McGee, J. G. Wells, B. R. Davis, R. J. Hebert, E. S. Olcott, L. M. Johnson, N. T. Hargrett, P. A. Blake, and M. L. Cohen. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685.
36. Siddons, C. A., and P. A. Chapman. 1993. Detection of serum and fecal antibodies in haemorrhagic colitis caused by Escherichia coli O157. J. Med. Microbiol. 39:408-415.
37. Thomas, A., H. R. Smith, and B. Rowe. 1993. Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157. J. Clin. Microbiol. 31:1700-1703.
38. van de Kar, N. C. A. J., H. G. R. Roelofs, H. L. Muytjens, J. J. M. Tolboon, H. Chart, and L. A. H. Monnens. 1994. Verocytotoxin-producing Escherichia coli infection in patients with hemolytic uremic syndrome and their family-members in the Netherlands, p. 45-48. In M. A. Karmali and A. G. Goglio (ed.), Recent advances in Verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam.
39. Wilson, J. B., R. C. Clarke, S. Renwick, K. Rahn, R. P. Johnson, D. Alves, M. A. Karmali, H. Lior, S. A. McEwen, and J. Spika. 1994. Verocytotoxigenic Escherichia coli infection on dairy farms in southern Ontario, p. 61-64. In M. A. Karmali, and A. G. Goglio (ed.), Recent advances in Verocytotoxin-producing Escherichia coli infections. Elsevier Science, Amsterdam.
40. Wilson, J. B., S. A. McEwen, R. C. Clarke, K. E. Leslie, R. A. Wilson, D. Waltner-Toews, and C. L. Gyles. 1992. Distribution and characteristics of verocytotoxigenic Escherichia coli isolated from Ontario dairy cattle. Epidemiol. Infect. 108:423-439.
41. Yamada, S., A. Kai, and Y. Kudoh. 1994. Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic-uremic syndrome. J. Clin. Microbiol. 32:955-959.